Predictive Oncology Inc. (POAI) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Predictive Oncology Inc. (POAI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.25

-0.03 (-2.34%)

At close: Jan 14, 2025, 3:59 PM

1.20

-4.00%

Pre-market Jan 15, 2025, 07:00 AM EST

undefined% (undefined)

Bid	1.18
Market Cap	8.33M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-2.96
PE Ratio (ttm)	-0.42
Forward PE	n/a
Analyst	Buy

Ask	1.27
Volume	217,809
Avg. Volume (20D)	1,146,422
Open	1.28
Previous Close	1.28
Day's Range	1.19 - 1.31
52-Week Range	0.55 - 3.76
Beta	undefined

About POAI

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery usi...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date May 3, 2010

Employees 34

Stock Exchange NASDAQ

Ticker Symbol POAI

Website https://www.predictive-oncology.com

Analyst Forecast

According to 2 analyst ratings, the average rating for POAI stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 140.00% from the latest price.

Buy 50.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

1 week ago · Source

+57.5%

Predictive Oncology shares are trading higher afte... Unlock content with Pro Subscription

1 week ago · Source

+12.2%

Predictive Oncology shares are trading higher after announcing the company is evaluating strategic alternatives including a potential sale.

News

1 week ago · businesswire.com

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Predictive Oncol...

1 week ago · businesswire.com

POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Predictive Oncology Inc. (NASDAQ: POAI) to Renovaro Inc. is fair to Predictive shareholde...